Infrastructure

Infrastructure

Reliance Life Sciences operates state-of-the-art facilities in life sciences domain.

The flagship facility is the Dhirubhai Ambani Life Sciences Centre (DALC) in Navi Mumbai, spread over 20 acres. DALC is among the most diverse and integrated life sciences campuses in the world. Its diversity stems from the wide spectrum of areas of research and development undertaken. Its integration comes from repository, laboratory research, pre-clinical research, clinical research and manufacturing facilities; all located in the same campus.

Research

The Dhirubhai Ambani Life Sciences Centre houses research labs over 120,000 sq ft of space and has the following laboratories:

  • Molecular Biology
  • Cell Culture
  • Fermentation
  • Downstream Purification
  • Virology
  • Molecular Medicine
  • Regenerative Medicine
  • Bioanalysis
  • API Development
  • Analytical Development
  • Formulation Development
  • Peptides
Dhirubhai Ambani Life Sciences Centre

These labs are supported by on-campus utility systems for power, water, HVAC and gases.

Cord Blood Repository

Reliance Life Sciences has established South Asia's first and most advanced stem cell enriched umbilical cord blood repository. This is the first cord blood repository in the country to be accorded a licence by an official regulatory authority, Drug Controller General of India, Government of India.

Pre-clinical facility

Reliance Life Sciences has established a state-of-the-art, barrier-maintained, animal facility for breeding and experimentation on small animals; to meet internal, as well as client needs. The facility breeds and maintains animals in individual ventilated cages (IVC) and conforms to the guidelines outlined by the Committee for the Purpose of Control and Supervision of Experiments on Animals (CPCSEA).

It is designed to carry out experiments on immuno-compromised animals in a Class 10,000 facility.

In the in-vitro facility, in addition to the general in-vitro toxicity studies, the facility is capable of handling cell-based efficacy studies.

Cord Blood Processing
cGMP Manufacturing
Plant 1 - Manufacturing facility for commercial sale manufacture of plasma proteins.
 
Plant 2 - Manufacturing facility for commercial manufacture of recombinant proteins, as well as cell-based therapies, is located in Navi Mumbai. This facility has suites both for mammalian cell culture and microbial fermentation, and is EMEA approved. It incorporates state-of-the-art distributed control systems.
 
Plant 3 - Kilo scale facility for Pharmaceutical APIs, with containment facilities for oncology products.
 
Plant 4 - Manufacturing facility for commercial scale manufacture of plasma proteins.
 
Plant 5 - Manufacturing facility for hyaluronic acid formulations.
 
Plant 6 - Manufacturing facility for oncology formulations (oral solid dosages and injectibles).
cGMP Manufacturing
Cell Processing

Reliance Life Sciences has four cGMP cell processing suites in operation in Mumbai to meet clinical trials for cell-based therapies and initial market introduction.

Quality Control

Reliance Life Sciences has state-of-the-art quality control facilities, which include stability chambers and microbiology suites.

The quality control laboratory for biopharmaceutical products is NABL accredited and approved by FDA Maharashtra. The quality control team is committed to provide high quality, safe and effective chemical and biological testing services to meet expectations of the healthcare community and customers.

Clinical Pharmacology

Reliance Life Sciences operates a Bioavailability/ Bioequivalence facility with two clinics (40 beds in each clinic). This facility is supported by an in-house pathology laboratory and bioanalytical facilities.